EXPIRED
NOT-MD-23-001 - Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
NOT-MD-22-003 - Notice to Change Eligibility in NOT-MD-22-001, "Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)"
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOT-OD-20-118- Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute on Drug Abuse (NIDA)
This Notice of Special Interest (NOSI) invites applications for administrative supplements to NIMHD Research Centers in Minority Institutions (RCMI) U54 awards to support pilot research projects led by early-stage investigators (ESIs) and new investigators (NIs) focused on research on substance use, addiction, and/or neuroscience, as a bridge to independently funded careers. To help achieve this goal, it is expected that pilot project PIs will prepare and submit follow-up research grant or career development applications to NIH based on the research supported by these supplemental funds.
Background
Every facet of the United States scientific research enterprise from basic laboratory research to clinical and translational research to policy formation requires superior intellect, creativity and a wide range of skill sets and viewpoints. NIH’s ability to help ensure that the nation remains a global leader in scientific discovery and innovation is dependent upon a pool of highly talented scientists from diverse backgrounds who will help to further NIH's mission (see Notice of NIH's Interest in Diversity, NOT-OD-20-031). Despite tremendous advancements in scientific research, information, educational and research opportunities are not equally available to all. NIH encourages institutions to diversify their student and faculty populations to enhance the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral and social sciences (see NOT-OD-20-031). Toward that end, NIMHD in partnership with the National Institute on Drug Abuse (NIDA) seeks to enhance the diversity ofthe pool of independent investigators, including those from underrepresented groups in the biomedical research workforce, specifically in the areas of substance abuse, addiction and neuroscience research through effective outreach and partnerships with Minority Serving Institutions..
NIMHD's Research Centers in Minority Institutions (RCMI) program supports specialized research centers in institutions that offer doctoral degrees in the health professions or health-related sciences and have an historical and current commitment to educating underrepresented students. Each RCMI U54 center includes an Investigator Development Core to support the development of postdoctoral fellows, junior faculty, and other early-stage investigators in basic biomedical, behavioral, and/or clinical sciences through a Pilot Project Program. Eligible investigators for pilot project support should be at the senior post-doctoral or fellowship level or assistant professor. Centers are expected to conduct outreach and recruitment strategies to enhance the diversity of the pool of applicant PIs,including investigators from underrepresented backgrounds, and to provide ongoing advice to pilot PIs as they conduct their research projects, submit publications based on their work, and apply for external funding such as mentored K-award or equivalent and ultimately an R01 grant as appropriate to their career level..
Research Objectives
Supplements awarded through this NOSI are intended to provide support to ESIs and NIs to conduct pilot studies in the areas of substance abuse, addiction and neuroscience research and collect data they can use to prepare for applications for independent funding. The proposed research can range from basic, to clinical, translation, epidemiology, services, and prevention, but must be relevant to the NIDA mission (see https://www.drugabuse.gov/about-nida/strategic-plan/executive-summary).
Eligibility to be a PI of a pilot project funded through this NOSI is limited to ESIs as defined by NIH (https://grants.nih.gov/policy/early-investigators/index.htm) with their primary appointment at an RCMI U54 recipient institution. NIs are defined by NIH as individuals who have not previously competed successfully for substantial, independent funding from NIH. Investigators maintain NI status if they have received any of the smaller research grants, training, infrastructure, and career awards that appear on this list: https://grants.nih.gov/policy/early-investigators/list-smaller-grants.htm. ESI and NI PIs should be positioned to submit an NIH grant application within two years of the supplement award date. Individuals from underrepresented groups, individuals with disabilities, and individuals from disadvantaged backgrounds are strongly encouraged to apply as PIs. Recipients will be invited to participate in NIDA-sponsored professional development activities.
For pilot projects examining the impact of the COVID-19 pandemic on substance use and/or addiction, investigators are encouraged to use NIH-supported COVID-19 specific survey item repositories and select existing survey items or protocol modules currently being fielded if consensus based measures (e.g., https://www.phenxtoolkit.org/collections/view/1) are not available. This is particularly important for efforts to rapidly assess the needs and impact of COVID-19 across different population groups, particularly vulnerable populations. See NOT-OD-20-118 for additional information and resources for COVID-19 research data harmonization and data sharing.
Applications not responsive to this NOSI:
Applications nonresponsive to these terms will be withdrawn for this NOSI initiative.
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
Administrative supplements proposed through PA-20-272 must be within the scope of the peer reviewed and approved parent RCMI U54 award, including competitive revisions. For the purposes of this NOSI, proposed pilot research projects must be administered by the parent RCMI U54 center's Investigator Development Core.
To be eligible for an Administrative Supplement under this NOSI, the parent RCMI U54 award must:
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
Scientific/Research Contact
Nathan Stinson, Jr., PhD, MD, MPH
National Institute on Minority Health and Health Disparities
Telephone: 301-594-8704
Email: stinsonn@mail.nih.gov
Angela Holmes, PhD
Office of Diversity and Health Disparities, National Institute on Drug Abuse
Telephone: 301-827-2487
Email: angela.holmes2@nih.gov
Fiscal/Grants Management Contact
Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Email: pg38h@nih.gov